- Home
- CMPS vs EDD Comparison
CMPS vs EDD Comparison
Compare CMPS & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- EDD
- Stock Information
- Founded
- CMPS 2020
- EDD 2007
- Country
- CMPS United Kingdom
- EDD United States
- Employees
- CMPS N/A
- EDD N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- CMPS Health Care
- EDD Finance
- Exchange
- CMPS Nasdaq
- EDD Nasdaq
- Market Cap
- CMPS 280.2M
- EDD 304.3M
- IPO Year
- CMPS 2020
- EDD N/A
- Fundamental
- Price
- CMPS $4.22
- EDD $4.53
- Analyst Decision
- CMPS Strong Buy
- EDD
- Analyst Count
- CMPS 6
- EDD 0
- Target Price
- CMPS $33.60
- EDD N/A
- AVG Volume (30 Days)
- CMPS 841.8K
- EDD 254.3K
- Earning Date
- CMPS 10-31-2024
- EDD 01-01-0001
- Dividend Yield
- CMPS N/A
- EDD 7.52%
- EPS Growth
- CMPS N/A
- EDD N/A
- EPS
- CMPS N/A
- EDD N/A
- Revenue
- CMPS N/A
- EDD N/A
- Revenue This Year
- CMPS N/A
- EDD N/A
- Revenue Next Year
- CMPS N/A
- EDD N/A
- P/E Ratio
- CMPS N/A
- EDD N/A
- Revenue Growth
- CMPS N/A
- EDD N/A
- 52 Week Low
- CMPS $4.00
- EDD $4.22
- 52 Week High
- CMPS $12.75
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- CMPS 37.99
- EDD 33.15
- Support Level
- CMPS $4.00
- EDD $4.69
- Resistance Level
- CMPS $4.91
- EDD $4.76
- Average True Range (ATR)
- CMPS 0.26
- EDD 0.05
- MACD
- CMPS 0.04
- EDD 0.00
- Stochastic Oscillator
- CMPS 24.18
- EDD 6.24
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.